Intravitreal Ranibizumab Treatment of Central Retinal Vein Occlusion With Macular Edema

NCT00403039 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Retinal Vein Occlusion

Interventions

DRUG: Ranibizumab (Lucentis )

Sponsor

Vitreous -Retina- Macula Consultants of New York

Collaborators

[object Object]